Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features

BACKGROUND AND PURPOSE: High-risk prostate cancer patients are frequently treated with external-beam radiotherapy (EBRT). Of all patients receiving EBRT, 15–35% will experience biochemical recurrence (BCR) within five years. Magnetic resonance imaging (MRI) is commonly acquired as part of the diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinis Fernandes, Catarina, Dinh, Cuong V., Walraven, Iris, Heijmink, Stijn W., Smolic, Milena, van Griethuysen, Joost J.M., Simões, Rita, Losnegård, Are, van der Poel, Henk G., Pos, Floris J., van der Heide, Uulke A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807756/
https://www.ncbi.nlm.nih.gov/pubmed/33458399
http://dx.doi.org/10.1016/j.phro.2018.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807756/
https://www.ncbi.nlm.nih.gov/pubmed/33458399
http://dx.doi.org/10.1016/j.phro.2018.06.005

Ejemplares similares